TOMI Environmental Solutions (TOMZ) Sidoti's Year End Virtual Investor Conference summary

Company overview and product innovation

• SteraMist offers rapid, eco-friendly disinfection using a patented cold plasma hydrogen peroxide process, producing only oxygen and humidity as byproducts.

• Technology originated from DARPA and is protected by 32 patents and 200+ trademarks, with registrations in 50 states and 30+ countries.

• Major clients span government agencies, pharma, healthcare, and food industries, including FDA, NASA, Pfizer, and Nestlé.

• Product portfolio includes portable, scalable, and integrated systems for diverse applications.

• OEM partnerships established in late 2024 are integrating SteraMist into global laboratory equipment.

Market segments and growth drivers

• Five key market segments: life sciences, food safety, commercial services, healthcare, and professional remediation.

• Life sciences and food safety are leading revenue contributors, with food safety rapidly growing.

• Regulatory trends and biosecurity needs post-COVID are driving demand, especially in high-containment labs and sterile environments.

• Shift away from ethylene oxide sterilization benefits SteraMist due to its safer byproducts.

• Academic and industry funding for infectious disease research presents significant future opportunities.

Business model and financial performance

• Razor-blade model: equipment sales drive installed base, leading to high-margin recurring consumable revenue.

• Gross margins are 60%-62%, with a 40% growth in the first half of 2025 compared to 2024.

• Revenue increased 38% over pre-COVID levels; service revenue has grown 50% post-pandemic.

• Active sales pipeline of $21 million, with $5 million in near-term bookings and a break-even point at $12 million.

• Expenses are mainly fixed, supporting margin stability as the company scales.